What are the age‑appropriate vitamin B12 (cobalamin) doses for children and the recommended treatment regimen for vitamin B12 deficiency?

Vitamin B12 Dosing in Children

For parenteral nutrition, preterm and term infants up to 12 months should receive 0.3 mcg/kg/day of cobalamin, and older children should receive 1 mcg/day. 1

Age-Specific Dosing for Parenteral Nutrition

Infants (0-12 months)

• Preterm and term infants: 0.3 mcg/kg/day of cobalamin via parenteral route 1
• This applies to all infants receiving parenteral nutrition regardless of gestational age at birth 1

Children (>12 months)

• Older children: 1 mcg/day of cobalamin 1
• These recommendations are based primarily on expert opinion due to limited evidence 1

Treatment of Vitamin B12 Deficiency

Oral Treatment (Nutritional Deficiency)

• High-dose oral therapy: 1000 mcg daily is effective for children with nutritional vitamin B12 deficiency 2
• Treatment duration: 4 months of oral therapy (1000 mcg) is effective, though younger children (1-20 months) respond better than older children 2
• Dosing regimen: Daily for 1 week, then every other day for 2 weeks, then 2 days per week for 2 weeks, then once weekly 2

Sublingual Treatment (Alternative Route)

• Children under 8 years: 500 mcg (1 puff) daily 3
• Children 8 years and older: 1000 mcg (2 puffs) daily 3
• Protocol: Daily for 1.5 months, then three times weekly for an additional 1.5 months 3
• Sublingual methylcobalamin is as effective as intramuscular cyanocobalamin in children aged 0-3 years 4
• Important: Hold spray in mouth for 1 minute and avoid food intake for 15 minutes after administration 3

Intramuscular Treatment (Pernicious Anemia or Severe Deficiency)

• Initial loading: 100 mcg daily for 6-7 days by intramuscular or deep subcutaneous injection 5
• Continuation: Same dose on alternate days for 7 doses, then every 3-4 days for 2-3 weeks 5
• Maintenance: 100 mcg monthly for life in pernicious anemia 5
• Pediatric intake recommendation: 0.5 to 3 mcg daily for general pediatric intake 5

Critical Clinical Considerations

Monitoring Requirements

• Initial assessment: Obtain serum B12, folate, iron levels, hematocrit, and reticulocyte count before treatment 5
• Early monitoring: Check hematocrit and reticulocyte counts daily from days 5-7 of therapy, then frequently until hematocrit normalizes 5
• Serum potassium: Must be monitored closely in the first 48 hours of treatment and replaced if necessary 5

Important Warnings

• Folic acid masking: Never give folic acid alone without B12 in suspected deficiency, as it may correct anemia but allow irreversible neurological damage to progress 5
• Neurological damage: B12 deficiency allowed to progress for longer than 3 months may produce permanent degenerative spinal cord lesions 5
• Maternal deficiency: Infants of vegetarian mothers who are breastfed are at risk for deficiency even when mothers are asymptomatic 5

Route Selection

• Avoid intravenous route: Almost all vitamin will be lost in urine 5
• Parenteral preferred: For pernicious anemia or malabsorption, parenteral B12 is required for life 5
• Oral acceptable: For nutritional deficiency with normal intestinal absorption, oral therapy is effective 2, 4

Special Populations

• Infants with feeding difficulties: Clinical suspicion should prompt immediate testing; plasma homocysteine >5.0 µmol/L indicates insufficiency requiring intramuscular hydroxycobalamin 6
• Post-surgical patients: Children after distal ileum resection, gastrectomy, or bariatric surgery are at high risk for deficiency 1
• Vegetarian/vegan diets: Require regular oral B12 supplementation as these diets provide no B12 5

Concomitant Deficiencies

• Always evaluate folate: Most symptoms overlap between B12 and folate deficiency 7
• Check iron status: May reveal complicating illness inhibiting marrow response 5
• If folate is low, administer folic acid concomitantly with B12 treatment 5